These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
413 related items for PubMed ID: 11014213
1. Effects of arsenite on estrogen receptor-alpha expression and activity in MCF-7 breast cancer cells. Stoica A, Pentecost E, Martin MB. Endocrinology; 2000 Oct; 141(10):3595-602. PubMed ID: 11014213 [Abstract] [Full Text] [Related]
6. Role of insulin-like growth factor-I in regulating estrogen receptor-alpha gene expression. Stoica A, Saceda M, Fakhro A, Joyner M, Martin MB. J Cell Biochem; 2000 Jan; 76(4):605-14. PubMed ID: 10653980 [Abstract] [Full Text] [Related]
10. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen. Herman ME, Katzenellenbogen BS. J Steroid Biochem Mol Biol; 1996 Oct; 59(2):121-34. PubMed ID: 9010327 [Abstract] [Full Text] [Related]
11. Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. Garcia-Morales P, Saceda M, Kenney N, Kim N, Salomon DS, Gottardis MM, Solomon HB, Sholler PF, Jordan VC, Martin MB. J Biol Chem; 1994 Jun 17; 269(24):16896-901. PubMed ID: 8207012 [Abstract] [Full Text] [Related]
12. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report. Han WD, Mu YM, Lu XC, Xu ZM, Li XJ, Yu L, Song HJ, Li M, Lu JM, Zhao YL, Pan CY. Endocr Relat Cancer; 2003 Jun 17; 10(2):217-24. PubMed ID: 12790785 [Abstract] [Full Text] [Related]
13. Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells. Oh AS, Lorant LA, Holloway JN, Miller DL, Kern FG, El-Ashry D. Mol Endocrinol; 2001 Aug 17; 15(8):1344-59. PubMed ID: 11463858 [Abstract] [Full Text] [Related]
16. Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells. Stoner M, Saville B, Wormke M, Dean D, Burghardt R, Safe S. Mol Endocrinol; 2002 Oct 17; 16(10):2231-42. PubMed ID: 12351689 [Abstract] [Full Text] [Related]
17. Comparative activity of pulsed or continuous estradiol exposure on gene expression and proliferation of normal and tumoral human breast cells. Cavaillès V, Gompel A, Portois MC, Thénot S, Mabon N, Vignon F. J Mol Endocrinol; 2002 Jun 17; 28(3):165-75. PubMed ID: 12063183 [Abstract] [Full Text] [Related]
18. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells. Steinmetz R, Young PC, Caperell-Grant A, Gize EA, Madhukar BV, Ben-Jonathan N, Bigsby RM. Cancer Res; 1996 Dec 01; 56(23):5403-9. PubMed ID: 8968093 [Abstract] [Full Text] [Related]
19. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells. Kim K, Thu N, Saville B, Safe S. Mol Endocrinol; 2003 May 01; 17(5):804-17. PubMed ID: 12576490 [Abstract] [Full Text] [Related]